A Systematic Review of Conversion From Calcineurin Inhibitor to Mammalian Target of Rapamycin Inhibitors for Maintenance Immunosuppression in Kidney Transplant Recipients
Authors:
Open Access
- 1 September 2014
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 14 (9) , 2106-2119
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- The ORION Study: Comparison of Two Sirolimus-Based Regimens versus Tacrolimus and Mycophenolate Mofetil in Renal Allograft RecipientsAmerican Journal of Transplantation, 2011
- Contrast Enhanced Sonography Shows Superior Microvascular Renal Allograft Perfusion in Patients Switched From Cyclosporine A to EverolimusTransplantation, 2009
- Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT TrialTransplantation, 2009
- Rapamycin for Treatment of Chronic Allograft Nephropathy in Renal Transplant PatientsJournal of the American Society of Nephrology, 2005
- A Randomized Controlled Trial of Late Conversion from CNI‐Based to Sirolimus‐Based Immunosuppression Following Renal TransplantationAmerican Journal of Transplantation, 2005
- Strategies to Improve Long-Term Outcomes after Renal TransplantationNew England Journal of Medicine, 2002
- Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric TransplantNew England Journal of Medicine, 1999
- PREDICTING GLOMERULAR FILTRATION RATE AFTER KIDNEY TRANSPLANTATIONTransplantation, 1995
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976